Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.227 USD
-3.81%
Market Closed
Updated:
May 21, 2024
Sonoma Pharmaceuticals Inc
Net Change in Cash
|
Sonoma Pharmaceuticals Inc
Net Change in Cash Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Net Change in Cash
-$224k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
36%
|
CAGR 10-Years
23%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Change in Cash
-$1.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Change in Cash
$286m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-23%
|
|
|
Pfizer Inc
NYSE:PFE
|
Net Change in Cash
-$1.4B
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Net Change in Cash
-$4.1B
|
CAGR 3-Years
-111%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Change in Cash
-$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-36%
|
See Also
What is Sonoma Pharmaceuticals Inc's Net Change in Cash?
Net Change in Cash
-224k
USD
-224k
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Net Change in Cash amounts to -224k USD.
What is Sonoma Pharmaceuticals Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
23%
23%
Over the last year, the Net Change in Cash growth was 96%.
You don't have any saved screeners yet
